Combined antagonism of Oncostatin M (OSM) and Interleukin 6 (IL-6) provides both anti-fibrotic and anti-inflammatory benefit in pulmonary fibrosisRojo Ratsimandresy, Mark S. Wilson, Christopher J. Wedeles et al.|bioRxiv (Cold Spring Harbor Laboratory)|2025Cited by 0
Selective blockade of latent TGF-β1 activation suppresses tissue fibrosis with good safetyMasakazu Kanamori, Hideaki Shimada|Communications Medicine|2026Cited by 0